COMPOSITIONS AND METHODS FOR TREATING CANCER
The present disclosure relates to compounds that are capable of penetrating the blood brain barrier to modulate the activity of EGFR tyrosine kinase. The disclosure further relates to methods of treating glioblastoma and other EGFR-mediated cancers, such as those that have been determined to have al...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Tsang, Jonathan Jung, Michael E Kim, Gyudong Nathanson, David A Urner, Lorenz Clark, Peter M Cloughesy, Timothy F |
| description | The present disclosure relates to compounds that are capable of penetrating the blood brain barrier to modulate the activity of EGFR tyrosine kinase. The disclosure further relates to methods of treating glioblastoma and other EGFR-mediated cancers, such as those that have been determined to have altered glucose metabolism in the presence of inhibitors. The present disclosure also provides methods of administering to a subject a glucose metabolism inhibitor and a cytoplasmic p53 stabilizer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023115366A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023115366A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023115366A13</originalsourceid><addsrcrecordid>eNrjZNBx9vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggJcnUM8fRzV3B29HN2DeJhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRsaGhqbGZmaOhsbEqQIANKsmIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR TREATING CANCER</title><source>esp@cenet</source><creator>Tsang, Jonathan ; Jung, Michael E ; Kim, Gyudong ; Nathanson, David A ; Urner, Lorenz ; Clark, Peter M ; Cloughesy, Timothy F</creator><creatorcontrib>Tsang, Jonathan ; Jung, Michael E ; Kim, Gyudong ; Nathanson, David A ; Urner, Lorenz ; Clark, Peter M ; Cloughesy, Timothy F</creatorcontrib><description>The present disclosure relates to compounds that are capable of penetrating the blood brain barrier to modulate the activity of EGFR tyrosine kinase. The disclosure further relates to methods of treating glioblastoma and other EGFR-mediated cancers, such as those that have been determined to have altered glucose metabolism in the presence of inhibitors. The present disclosure also provides methods of administering to a subject a glucose metabolism inhibitor and a cytoplasmic p53 stabilizer.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230413&DB=EPODOC&CC=US&NR=2023115366A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230413&DB=EPODOC&CC=US&NR=2023115366A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Tsang, Jonathan</creatorcontrib><creatorcontrib>Jung, Michael E</creatorcontrib><creatorcontrib>Kim, Gyudong</creatorcontrib><creatorcontrib>Nathanson, David A</creatorcontrib><creatorcontrib>Urner, Lorenz</creatorcontrib><creatorcontrib>Clark, Peter M</creatorcontrib><creatorcontrib>Cloughesy, Timothy F</creatorcontrib><title>COMPOSITIONS AND METHODS FOR TREATING CANCER</title><description>The present disclosure relates to compounds that are capable of penetrating the blood brain barrier to modulate the activity of EGFR tyrosine kinase. The disclosure further relates to methods of treating glioblastoma and other EGFR-mediated cancers, such as those that have been determined to have altered glucose metabolism in the presence of inhibitors. The present disclosure also provides methods of administering to a subject a glucose metabolism inhibitor and a cytoplasmic p53 stabilizer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBx9vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggJcnUM8fRzV3B29HN2DeJhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRsaGhqbGZmaOhsbEqQIANKsmIA</recordid><startdate>20230413</startdate><enddate>20230413</enddate><creator>Tsang, Jonathan</creator><creator>Jung, Michael E</creator><creator>Kim, Gyudong</creator><creator>Nathanson, David A</creator><creator>Urner, Lorenz</creator><creator>Clark, Peter M</creator><creator>Cloughesy, Timothy F</creator><scope>EVB</scope></search><sort><creationdate>20230413</creationdate><title>COMPOSITIONS AND METHODS FOR TREATING CANCER</title><author>Tsang, Jonathan ; Jung, Michael E ; Kim, Gyudong ; Nathanson, David A ; Urner, Lorenz ; Clark, Peter M ; Cloughesy, Timothy F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023115366A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Tsang, Jonathan</creatorcontrib><creatorcontrib>Jung, Michael E</creatorcontrib><creatorcontrib>Kim, Gyudong</creatorcontrib><creatorcontrib>Nathanson, David A</creatorcontrib><creatorcontrib>Urner, Lorenz</creatorcontrib><creatorcontrib>Clark, Peter M</creatorcontrib><creatorcontrib>Cloughesy, Timothy F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Tsang, Jonathan</au><au>Jung, Michael E</au><au>Kim, Gyudong</au><au>Nathanson, David A</au><au>Urner, Lorenz</au><au>Clark, Peter M</au><au>Cloughesy, Timothy F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR TREATING CANCER</title><date>2023-04-13</date><risdate>2023</risdate><abstract>The present disclosure relates to compounds that are capable of penetrating the blood brain barrier to modulate the activity of EGFR tyrosine kinase. The disclosure further relates to methods of treating glioblastoma and other EGFR-mediated cancers, such as those that have been determined to have altered glucose metabolism in the presence of inhibitors. The present disclosure also provides methods of administering to a subject a glucose metabolism inhibitor and a cytoplasmic p53 stabilizer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023115366A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | COMPOSITIONS AND METHODS FOR TREATING CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A55%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Tsang,%20Jonathan&rft.date=2023-04-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023115366A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |